Recruiting
Acute myeloid leukaemia refractory+2
RecruitingPhase 1/2 Study of LB-208 in Adults with Relapsed or Refractory Acute Myeloid Leukaemia and High‑Risk Myelodysplastic Syndrome
InvestigationalNo placebo
Phase 1/2 Study of LB-208 in Adults with Relapsed or Refractory Acute Myeloid Leukaemia and High‑Risk Myelodysplastic Syndrome
InvestigationalNo placebo
- Disease:Acute myeloid leukaemia refractoryAcute myeloid leukaemia recurrent+1
- Substances:LB-208
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:LB-208
